These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 3476764)
61. Low-dose cytarabine therapy in hypoplastic acute leukemia. Manoharan A N Engl J Med; 1983 Dec; 309(26):1652-3. PubMed ID: 6580525 [No Abstract] [Full Text] [Related]
62. In vitro sensitivity of various human tumors to 1-beta-D-arabinofuranosylcytosine and N4-behenoyl-1-beta-D-arabinofuranosylcytosine. Maehara Y; Kusumoto T; Kusumoto H; Anai H; Sugimachi K Chemotherapy; 1989; 35(3):181-6. PubMed ID: 2766858 [TBL] [Abstract][Full Text] [Related]
63. [Successful treatment of chronic myelomonocytic leukemia (CMMoL) with N4-palmitoyl-1-beta-D-arabinofuranosylcytosine (PLAC)]. Ozawa M; Iwamoto K; Kitani K; Mizuno T; Kobayashi Y; Horiuchi H; Maruo N; Kondo M; Horiike S; Misawa S Rinsho Ketsueki; 1988 Dec; 29(12):2297-301. PubMed ID: 3246714 [No Abstract] [Full Text] [Related]
64. [The effect of N4-behenoyl-1-beta-D-arabinofuranosylcytosine on human erythrocytes]. Moriguchi T; Kakita T; Nishimura T; Kubo A; Ueda T; Nakamura T; Sasada M; Uchino H Rinsho Ketsueki; 1987 Sep; 28(9):1568-75. PubMed ID: 3437519 [No Abstract] [Full Text] [Related]
65. [High-dose cytarabine therapy in acute myeloid leukemia]. Kawamura M; Ohshima T Rinsho Ketsueki; 1986 Aug; 27(8):1468-75. PubMed ID: 3467104 [No Abstract] [Full Text] [Related]
66. Antiviral effect of antileukemic drugs N4-behenoyl-1-beta-D-arabinofuranosylcytosine (BH-AC) and 2,2'-anhydro-1-beta-D-arabinofuranosylcytosine (cyclo-C) against human cytomegalovirus. Nakamura K; Eizuru Y; Kumura K; Minamishima Y J Med Virol; 1990 Jun; 31(2):141-7. PubMed ID: 1696958 [TBL] [Abstract][Full Text] [Related]
67. Cytokinetic study on the effects of N4-behenoyl-1-beta-D-arabinofuranosylcytosine on murine leukemic cells L 1210: a comparison with the effects of 1-beta-D-arabinofuranosylcytosine. Maruo N; Horiuchi H; Nakabo T; Kondo M; Nakamura T Hematol Oncol; 1985; 3(1):39-48. PubMed ID: 2580770 [TBL] [Abstract][Full Text] [Related]
68. [Influences of aging on clinical pictures of hematological diseases: hypoplastic leukemia in the aged]. Ohnoshi T; Takahashi I; Ohmoto E; Nakada H; Nishimura M; Nonaka K Nihon Ronen Igakkai Zasshi; 1987 Mar; 24(2):128-31. PubMed ID: 3476778 [No Abstract] [Full Text] [Related]
74. Phase I clinical and pharmacokinetic study of N4-behenoyl-1-beta-D-arabinofuranosylcytosine. Kimura K; Ohno R; Amaki I; Hattori K; Hirota Y; Hoshino A; Ichimaru M; Ito M; Kimura I; Maekawa T Med Oncol Tumor Pharmacother; 1986; 3(1):15-24. PubMed ID: 3702507 [TBL] [Abstract][Full Text] [Related]
75. [Acute myeloid leukemia. Effects of treatment and prognosis]. Johnsen HE; Bergmann OJ; Madsen B; Kristensen JS; Brandsborg M; Ellegaard J; Bastrup-Madsen P Ugeskr Laeger; 1987 Jun; 149(24):1598-603. PubMed ID: 3474820 [No Abstract] [Full Text] [Related]
76. Phase I clinical and pharmacokinetic study of orally administered N4-palmitoyl-1-beta-D-arabinofuranosylcytosine. Ohno R; Kimura K; Ota K; Miura Y; Hoshino A; Hattori K; Hirano M; Ito M; Maekawa T; Nakamura T Med Oncol Tumor Pharmacother; 1987; 4(2):67-73. PubMed ID: 3669779 [TBL] [Abstract][Full Text] [Related]
77. [High dose androgen therapy: an adjuvant means in the aggressive treatment of acute myeloblastic leukemia? 1st results]. Tanzer J; Desmaret MC; Frocrain C; Alcalay D; Nivet-Perdoux A; Goube de LaForest P Nouv Presse Med; 1976 Nov; 5(38):2543. PubMed ID: 1068442 [No Abstract] [Full Text] [Related]
78. Low-dose combination remission induction therapy for acute myeloid leukaemia in elderly patients--a pilot study. Manoharan A Aust N Z J Med; 1992 Dec; 22(6):710-1. PubMed ID: 1489302 [No Abstract] [Full Text] [Related]
79. Intracellular pharmacokinetics of N4-behenoyl-1-beta-D-arabinofuranosylcytosine. Higashigawa M; Hori H; Ochiai H; Ohkubo T; Kawasaki H; Nobori T; Kamiya H; Sakurai M Adv Exp Med Biol; 1989; 253B():341-8. PubMed ID: 2610121 [No Abstract] [Full Text] [Related]